⚫ Exerts gastro-kinetic effect by enhancing acetylcholine release
⚫ Improves upper gastrointestinal motility to relieve abdominal symptoms arising due to impaired GI motility in FD patients
⚫ Approved in India in 2016 for the treatment of bloating after meals, epigastric bloating and early satiety in FD patients
⚫ Has the potential to be a promising gastroprokinetic agent for FD because of its efficacy without any significant adverse events